Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.
about
Hydralazine in infants with persistent hypoxemic respiratory failureHydralazine for pulmonary hypertension in low birth weight infants with chronic lung diseaseRole of endothelin in uteroplacental circulation and fetal vascular functionSafety and tolerability of targeted therapies for pulmonary hypertension in children.
P2860
Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.
@en
Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.
@nl
type
label
Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.
@en
Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.
@nl
prefLabel
Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.
@en
Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.
@nl
P2093
P2860
P1476
Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.
@en
P2093
Jeffrey R Fineman
Peter Oishi
Sanjeev A Datar
P2860
P304
P356
10.1517/14656566.2011.585636
P407
P577
2011-05-25T00:00:00Z